Kongnakorn, Thitima
Eckmann, Christian
Bassetti, Matteo
Tichy, Eszter
Di Virgilio, Roberto
Baillon-Plot, Nathalie
Charbonneau, Claudie
Funding for this research was provided by:
Pfizer UK (N/A)
Article History
Received: 6 September 2019
Accepted: 13 November 2019
First Online: 21 December 2019
Ethics approval and consent to participate
: Not Applicable.
: Not Applicable.
: TK and ET are employees of Evidera, which received funding from Pfizer in connection with conducting the study, developing this manuscript, and medical writing. RDV, NBP, and CC are employees of Pfizer, and hold Pfizer stock and/or stock options. CE is an employee of Klinikum Peine, Academic Hospital of Medical University Hannover, (Hannover, Germany), and MB is an employee of University of Genoa, Genoa and Hospital Policlinico San Martino – IRCCS, Genoa (Italy), each of which received research funding from Pfizer. Outside the submitted work, MB has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, AstraZeneca, Bayer, Cidara, Cepheid, Cubist, Pfizer, Menarini, MSD, Nabriva, Paratek, Roche, Shionogi, Tetraphase, The Medicine Company and Astellas Pharma Inc.